Xeris Pharmaceuticals | XERS - 市值



金融业
股票价格
USD
资产
USD 370.19M
现金及等价物
USD 91.6M
销售成本
USD 13.71M
流动资产
USD 224.02M
流动负债
USD 116.2M
债务
USD 257.65M
EBIT
USD 7.89M
EBITDA
USD 17.42M
员工
377
EPS每股收益
USD 0
股本和储备
USD -861K
销售毛利
USD 63.38M
债务利息支出
USD 7.27M
利息收入
USD 1.16M
贷款资金
USD 219.47M
市值
USD 771.1M
净收入
USD 621K
营业费用
USD 67.65M
营业利润
USD 6.73M
普通股股本
USD 165.53M
税前利润
USD 621K
销售收入
USD 74.38M
销售和管理费用
USD 46.46M
股票
USD 67.46M
贸易债权人
USD 6.53M
应收帐款人
USD 53.75M


市值 更改 日
Cspc Pharmaceutical CNY 107.03B 26.09B 2025-09
Deva Holding AS TRY 17.54B 7.76B 2023-09
Dianthus Therapeutics USD 1.57B 967M 2025-09
Divis Laboratories Ltd INR 1.7T 186.62B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Kangmei Pharma CNY 27.93B 1.73B 2025-09
Knight Therapeutics CAD 624.22M 38.25M 2026-03
Laboratorios Farma EUR 4.16B 904.2M 2026-03
Malin Corporation EUR 142.92M 19.65M 2026-02
Medical Developments International AUD 38.41M 24.12M 2026-03
Neuren Pharmaceuticals AUD 1.71B 645.78M 2026-03
Organigram Holdings CAD 378.8M 132.2M 2025-09
Ovoca Bio EUR 7.54M 4.28M 2022-06
Pacira USD 1.06B 94M 2025-12
Perrigo USD 1.92B 1.04B 2025-12
Pharma Mar EUR 1.41B 63.87M 2026-03
Qiagen NV USD 9.9B 207.4M 2025-12
Sartorius EUR 16.41B 2.95B 2025-12
Sino Biopharmaceutical CNY 114.44B 24.38B 2026-03
Supernus Pharmaceuticals USD 2.85B 151M 2025-12
Zealand Pharma A/S 33.35B 0 2026-02
Zz Pientze Pharmaceu CNY 118.73B 1.94B 2025-09